文献速递乳房整形与再造显微修复重建创面修复

乳房再造腹部游离皮瓣术中应用补片加强腹壁:是否有益?风险何在?

Using Mesh to Reinforce the Abdominal Wall in Abdominal Free Flaps for Breast Reconstruction: Is There a Benefit? What are the Risks?
PubMed 文献 · Ann Plast Surg · 2018-01-01

该研究回顾性分析了2005至2015年斯坦福医疗中心380例腹部游离皮瓣乳房再造患者,其中161例使用补片、219例未使用。多因素校正逻辑回归显示补片组腹部膨出风险显著降低(OR 0.30,P=0.01),疝和感染风险无显著差异;作者认为对疝和膨出高危的选定患者使用补片安全且有益。

要点

  • 补片组腹部膨出7例(4.3%),无补片组17例(7.8%),补片与膨出风险降低显著相关(OR 0.30,P=0.01)。
  • 补片组疝0例(0.0%),无补片组5例(2.3%),差异无统计学意义(OR 2.26E-10,P=0.99)。
  • 补片组感染11例(6.8%),无补片组11例(5.0%),差异无统计学意义(OR 1.21,P=0.69)。

核心结论

  • 作者确认接受补片的患者腹部膨出和疝的风险降低。
  • 伤口感染风险与补片使用无关,体重指数升高、闭合张力和其他合并症更可能是浅表伤口并发症的原因。
  • 作者认为对接受腹部游离皮瓣乳房再造、有疝和膨出风险的选定患者,使用补片安全且有益。

研究设计与样本

  • 回顾性研究,纳入2005至2015年斯坦福医疗中心所有因乳房再造行腹部游离皮瓣切取的患者380例。
  • 161例接受补片,219例未接受补片加强。
  • 采用多因素校正逻辑回归分析比较两组腹部并发症(感染、膨出、疝)的比值比。

主要发现

  • 补片组腹部膨出7例(4.3%),无补片组17例(7.8%),膨出比值比有显著差异(OR 0.30,P=0.01)。
  • 补片组疝0例(0.0%),无补片组5例(2.3%),疝比值比无显著差异(OR 2.26E-10,P=0.99)。
  • 补片组腹部感染11例(6.8%),无补片组11例(5.0%),感染比值比无显著差异(OR 1.21,P=0.69)。

临床怎么用

  • 作者所在机构的当前治疗方案中,患者是否接受补片基于肥胖、术中发现的筋膜薄弱和广泛肌肉剥离等标准进行选择。
  • 作者认为对接受腹部游离皮瓣乳房再造、有疝和膨出风险的选定患者,使用补片安全且有益。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Abdominal wall integrity may be compromised after abdominal flap harvest for breast reconstruction, leading to bulging or herniation due to weakening of the abdominal wall and dissection through the rectus muscle. Mesh can be used to reinforce the abdominal wall to reduce the risk of hernia formation postoperatively, especially in patients who may be at high risk. In this study, we describe this institution's experience with the use of mesh in the abdominal wall and critically evaluate its impact on patient outcomes and complications. METHODS: We retrospectively reviewed all patients with an abdominal free flap harvested for breast reconstruction at Stanford Health Care from 2005 to 2015. Multivariate-adjusted logistic regression analysis was used to compare the odds of abdominal complications-infection, bulging, and herniation-between patients with and without an abdominal mesh implanted during breast reconstruction. RESULTS: Three hundred eighty patients met inclusion criteria. One hundred sixty-one patients received mesh, whereas 219 received no reinforcement. In the mesh group, there were 7 (4.3%) cases of postoperative abdominal bulging, 11 (6.8%) cases of abdominal infection, and no (0.0%) cases of herniation. In the group without mesh, there were 17 (7.8%) cases of abdominal bulging, 11 (5.0%) cases of abdominal infection, and 5 (2.3%) cases of herniation. There was a significant difference in the odds of bulging (odds ratio [OR], 0.30; P = 0.01). There was not a significant difference in the odds of herniation (OR, 2.26E-10; P = 0.99) or infection (OR, 1.21; P = 0.69). CONCLUSIONS: In our current treatment algorithm, patients who received mesh were selected based upon several criteria, including obesity, weak fascia identified during surgery, and extensive muscle dissection. We confirm that the risk of bulging and herniation is decreased in patients receiving mesh. Furthermore, the risk of wound infection was not associated with the use of mesh; instead, a patient's elevated body mass index, as well as tension of closure, and other comorbidities are more likely causes of superficial wound complications. We find the use of mesh to be safe and beneficial in select patients undergoing abdominal free flap breast reconstruction who are at risk for hernias and bulges.

来源:Ann Plast Surg,查看原文。版权归原作者所有。

引用

  1. Leon DS, Nazerali R, Lee GK, et al. Using Mesh to Reinforce the Abdominal Wall in Abdominal Free Flaps for Breast Reconstruction: Is There a Benefit? What are the Risks? Ann Plast Surg. 2018. PMID: 29596090. doi:10.1097/SAP.0000000000001468

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。